Abstract: The present disclosure proposes a channel quality indicator (CQI) feedback method applicable to a user equipment (UE) using the same method. According to one of the exemplary embodiments, the channel quality indicator (CQI) feedback method would be applicable to a user equipment (UE) and would include steps of at least but not limited to receiving a N×L precoding matrix having N rows and L columns with each of the N rows corresponding to an antenna port and each of the L columns corresponding to a user, wherein N and L are both integers greater than one, performing a channel quality indicator (CQI) calculation for K of the L columns, where 0<K?L, and K is an integer, determining from the CQI calculation for K of the L columns a preferred column, and transmitting information corresponding to the preferred column.

Abstract: Provided are a ceria-based composition having an undoped or metal-doped ceria and an undoped or metal-doped bismuth oxide, wherein the undoped or metal-doped bismuth oxide is present in an amount equal to or more than about 10 wt % and less than about 50 wt % based on the total weight of the ceria-based composition, and at least one selected from the ceria and the bismuth oxide is metal-doped. The ceria-based composition may ensure high sintering density even at a temperature significantly lower than the known sintering temperature of about 1400° C., i.e., for example at a temperature of about 1000° C. or lower, and increase ion conductivity as well.

Abstract: A scheduling method of giving a chance for transmission to a plurality of terminals in the same time period, and a device therefor are provided. The scheduling method includes: transmitting first scheduling information to terminals in a network, the first scheduling information defining transmitting/receiving terminals and a transmission time period; receiving channel measurement information including inter-terminal interference information from the terminals in the network; and generating second scheduling information defining transmission time periods and a plurality of transmitting/receiving terminals that do not interfere with each other by using the channel measurement information.

Abstract: Disclosed herein are an apparatus and method for controlling a lighting network. The apparatus for controlling lighting network includes a control device and a plurality of control gears. The control device generates and transfers commands to control lighting. The plurality of control gears receives the commands from the control device and control lighting. The control device assigns a right to use a lighting network to the control gears, and the control gears send information about a change in a lighting state or error details to the control device using the right to use a lighting network.

Abstract: A medicament for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ornithine decarboxylase (ODC) activity level, the medicament includes putrescine. A use of putrescine for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels. A method for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels by administering putrescine.

Abstract: An augmented reality system includes a plurality of mobile devices. Each mobile device includes: an image capturing unit capturing a real image of a target marker to generate a captured image; a storage unit storing a reference image of the target marker, an individual virtual object and a plurality of interactive composite virtual objects; a wireless communication unit capable of short-distance wireless communication with another mobile device located within a predetermined range; a processing unit determining whether the captured image matches the reference image; and a display unit controlled by the processing unit to display one of the individual virtual object, the interactive composite virtual objects and the captured image.

Abstract: The present invention provides a pharmaceutical composition, and methods of use thereof, for treating ocular boundary deficiency, symptoms associated therewith, or undesired condition that is associated with or causes ocular boundary deficiency at the ocular surface. The pharmaceutical composition of the present invention comprises a human PRG4 protein, a lubricant fragment, homolog, or isoform thereof, suspended in an ophthalmically acceptable balanced salt solution. The pharmaceutical composition of the present invention may also comprise one or more ophthalmically acceptable agents selected from the group consisting of an ophthalmically acceptable demulcent, excipient, astringent, vasoconstrictor, emollient, sodium hyaluronate, hyaluronic acid, and surface active phospholipids, in a pharmaceutically acceptable carrier for topical administration.

Abstract: This disclosure provides a computer-program product, system, method and apparatus for accessing a representation of a category or item and accessing a set of multiple transactions. The transactions are processed to identify items found amongst the transactions, and the items are ordered based on an information-gain heuristic. A depth-first search for a group of best association rules is then conducted using a best-first heuristic and constraints that make the search efficient. The best rules found during the search can then be displayed to a user, along with accompanying statistics. The user can then select rules that appear to be most relevant, and further analytics can be applied to the selected rules to obtain further information about the information provided by these rules.

Abstract: A method of manufacturing a metal foil with microcracks includes placing a metal foil between a first material sheet and a second material sheet and then rolling them to form a plurality of microcracks in the metal foil. The microcracks are penetrating, and a sidewall of each of the microcracks is an irregular rough surface. Two ends of each of the microcracks are acute angles. A sound-absorbing structure includes at least one metal foil and a base plate kept at a distance from the metal foil, wherein at least one resonant cavity air layer is formed between the metal foil and the base plate by the distance, and the metal foil has microcracks.

Abstract: Disclosed are a type of catalyst which can catalyze the ring-addition reaction of CO2 and an alkylene oxide at 0˜180° C. under 0.1˜8.0 MPa to produce a corresponding cyclic carbonate, and the preparation thereof. The catalyst is a conjugated microporous macromolecule polymer complexed with cobalt, chromium, zinc, copper or aluminum, and by using the macromolecule catalysts complexed with different metals to catalyze the reaction of CO2 and alkylene oxide at normal temperature and normal pressure, a yield of the corresponding cyclic carbonate of 35%˜90% can be obtained. The catalyst is easy to recover and the re-use of the catalyst has no influence on the yield; additionally, the yield can reach over 90% by controlling the reaction conditions.

Abstract: Disclosed is a detection method for detecting a specific cell in a sample containing multiple cells including the specific cell. Specifically disclosed is a detection method for detecting a specific cell in a sample containing multiple cells including the specific cell, which comprises the following steps (1) and (2): (1) retaining cells contained in the sample on a microarray chip which comprises multiple microchambers, wherein each of the microchambers can contain multiple cells; and (2) confirming the presence or absence of the specific cell in the cells retained on the microarray chip.

Abstract: The present disclosure relates to CBH II chimera fusion polypeptides, nucleic acids encoding the polypeptides, and host cells for producing the polypeptides.

Abstract: A method for manufacturing a semiconductor device that comprises two opposite types of MOSFETs formed on one semiconductor substrate, comprising: defining an active region for each of the MOSFETs on the semiconductor substrate; forming an interfacial oxide layer on a surface of the semiconductor substrate; forming a high-K gate dielectric layer on the interfacial oxide layer; forming a metal gate layer on the high-K gate dielectric layer; implanting dopant ions in the metal gate layer; forming a Poly-Si layer on the metal gate layer; patterning the Poly-Si layer, the metal gate layer, the high-K gate dielectric layer and the interfacial oxide layer to form a plurality of gate stack structures; forming a plurality of gate spacer surrounding each of the plurality of gate stack structures; and forming a plurality of S/D regions.

Abstract: Described herein are inhibitors of Aurora kinase and their use in the treatment of cancer. Methods of screening for selective inhibitors of Aurora kinases are also disclosed.

Abstract: An air conditioning control device and a method thereof are provided, and the air conditioning control method includes the following steps. A plurality of predetermined state information and a current state information are generated according to environment states of a physical space, and a target state information is selected form the plurality of predetermined state information according to a minimum energy consumption. Moreover, the current state information and the target state information are utilized to generate a current effective temperature value and a target effective temperature value, and a set temperature value and a return-air temperature value are extracted from an air conditioning controller. The current effective temperature value, the target effective temperature value, the set temperature value and the return-air temperature value are utilized to execute fuzzy inference to generate a temperature fine-tuning value.

Abstract: The invention relates to neutralizing antibodies, and antibody fragments thereof, having high potency in neutralizing hCMV, wherein said antibodies and antibody fragments are specific for one, or a combination of two or more, hCMV gene UL products. The invention also relates to immortalized B cells that produce, and to epitopes that bind to, such antibodies and antibody fragments. In addition, the invention relates to the use of the antibodies, antibody fragments, and epitopes in screening methods as well as in the diagnosis, prevention, and therapy of disease.

Abstract: The present invention provides novel enterobactin-carrier protein conjugates and salmochelin-carrier protein conjugates, such as compounds of Formula (I), and salts thereof. The present invention also provides compositions, kits, and methods that involve the compounds of Formula (I) and are useful in inducing an immune response, treating a bacterial infection and/or inflammatory bowel disease in a subject, preventing a bacterial infection and/or inflammatory bowel disease in a subject, or inhibiting the growth of or killing a bacterium.

Abstract: A bearing test apparatus has a bearing cap coupled to an outer ring of a bearing to be tested (a “test bearing”), a driving rotary shaft coupled to an inner ring of the test bearing to rotate the inner ring, and a bearing torque meter for measuring a single torque of the test bearing, wherein an extension bar is formed at the bearing cap to protrude thereon, wherein the bearing torque meter includes a measurement rod configured to contact the extension bar and be fixed to support the extension bar in a direction opposite to a rotating direction of the driving rotary shaft, and a power sensor for measuring a force applied to the measurement rod, wherein the single torque of the test bearing is calculated based on a distance from the driving rotary shaft to the measurement rod and a force applied to the measurement rod.

Abstract: An apparatus for recycling propylene includes a first propylene recovery column, a flash tank, a second propylene recovery column, and a depropanizing column. The apparatus can effectively solve the problem of high power consumption in the prior art, and can be used for the industrial manufacturing of propylene recovery from a propylene oxide apparatus. A process for recycling and refining propylene also is described.